Application 200563

Type
ANDA
Sponsor
LUPIN LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CIPROFLOXACINCIPROFLOXACINFOR SUSPENSION;ORAL250MG/5MLNoNo
002CIPROFLOXACINCIPROFLOXACINFOR SUSPENSION;ORAL500MG/5MLNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
68180-392CIPROFLOXACINCIPROFLOXACINLupin Pharmaceuticals, Inc.ANDACurrent
68180-393CIPROFLOXACINCIPROFLOXACINLupin Pharmaceuticals, Inc.ANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
9829ORIG2014-03-06